Straumann (OTCMKTS:SAUHY) Shares Gap Up – Should You Buy?

Straumann Holding AG (OTCMKTS:SAUHY) shares gapped up before the market opened on Wednesday . The stock had previously closed at $11.41, but opened at $12.02. Straumann shares last traded at $11.53, with a volume of 4,688 shares changing hands.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Barclays reiterated an “overweight” rating on shares of Straumann in a research report on Thursday, June 18th. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft cut Straumann from a “buy” rating to a “hold” rating in a research report on Friday, August 21st. BMO Capital Markets started coverage on shares of Straumann in a research note on Wednesday, July 8th. They set an “outperform” rating on the stock. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a report on Thursday, July 9th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold”.

Straumann Stock Performance

The business has a fifty day simple moving average of $12.58 and a two-hundred day simple moving average of $11.70.

About Straumann

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.